×

Atai Life Sciences Return on Investment 2020-2024 | ATAI

Current and historical return on investment (ROI) values for Atai Life Sciences (ATAI) over the last 10 years.
Atai Life Sciences ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2024-09-30 $-0.11B $0.17B -49.65%
2024-06-30 $-0.11B $0.19B -45.31%
2024-03-31 $-0.12B $0.24B -45.70%
2023-12-31 $-0.13B $0.26B -48.60%
2023-09-30 $-0.13B $0.29B -49.29%
2023-06-30 $-0.14B $0.23B -52.17%
2023-03-31 $-0.14B $0.26B -49.23%
2022-12-31 $-0.14B $0.28B -45.35%
2022-09-30 $-0.15B $0.31B -43.90%
2022-06-30 $-0.15B $0.32B -38.19%
2022-03-31 $-0.17B $0.36B -40.61%
2021-12-31 $-0.14B $0.39B -37.01%
2021-09-30 $-0.18B $0.46B -60.51%
2021-06-30 $-0.15B $0.49B -85.55%
2021-03-31 $-0.10B $0.12B -174.55%
2020-12-31 $-0.10B $0.10B -424.49%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.268B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.257B 0.00
Quest Diagnostics (DGX) United States $16.849B 17.08
DaVita (DVA) United States $12.285B 15.89
Encompass Health (EHC) United States $9.254B 21.82
Chemed (CHE) United States $7.946B 24.42
Elanco Animal Health (ELAN) United States $5.957B 14.18
RadNet (RDNT) United States $5.193B 115.00
Option Care Health (OPCH) United States $3.863B 18.31
Amedisys (AMED) United States $2.977B 21.19
LifeStance Health (LFST) United States $2.889B 0.00
Addus HomeCare (ADUS) United States $2.253B 26.44
Astrana Health (ASTH) United States $1.811B 24.77
U.S Physical Therapy (USPH) United States $1.327B 34.87
Pennant (PNTG) United States $0.909B 36.75
Aveanna Healthcare Holdings (AVAH) United States $0.871B 0.00
Bioqual (BIOQ) United States $0.058B 0.00
Daxor (DXR) United States $0.037B 0.00
Ontrak (OTRK) United States $0.008B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00
Psychemedics (PMD) United States $0.000B 0.00